Patents by Inventor Charles A. Sherman

Charles A. Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tablets comprising modafinil
    Publication number: 20040170683
    Abstract: A pharmaceutical tablet comprising modafinil particles, wherein more than 5% of the modafinil particles have a diameter of more than 200 microns, less than 5% of the modafinil particles have a diameter of more than 800 microns, and the tablet has a disintegration time of less than 20 minutes.
    Type: Application
    Filed: February 20, 2004
    Publication date: September 2, 2004
    Inventor: Bernard Charles Sherman
  • Pharmaceutical compositions comprising moexipril magnesium
    Patent number: 6767556
    Abstract: Stable solid compositions comprising moxeipril magnesium can be made using moexipril or an acid addition salt thereof, by reacting the moxeipril or acid addition salt with an alkaline magnesium compound in the presence of a solvent, so as to convert most or all of the moexipril or acid addition salt to moexipril magnesium.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: July 27, 2004
    Inventor: Bernard Charles Sherman
  • Pharmaceutical tablets comprising an NSAID and a prostaglandin
    Patent number: 6740340
    Abstract: A pharmaceutical tablet which incorporates two smaller tablets, one of which comprises an NSAID and the other of which comprises misoprostol.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: May 25, 2004
    Inventor: Bernard Charles Sherman
  • Benazepril hydrochloride tablet formulations
    Patent number: 6737419
    Abstract: Stable tablets comprising benazepril hydrochloride are prepared by employing zinc stearate as the lubricant.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: May 18, 2004
    Inventor: Bernard Charles Sherman
  • Magnesium omeprazole
    Patent number: 6713495
    Abstract: Improved process to produce magnesium omeprazole substantially amorphous with pharmaceutically acceptable low level of methanol and solid pharmaceutical compositions.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: March 30, 2004
    Inventor: Bernard Charles Sherman
  • Extended-release tablets comprising divalproex sodium
    Publication number: 20040005357
    Abstract: Extended-release tablets comprising divalproex sodium and a water-insoluble polymer wherein the amount of divalproex sodium exceeds 80% of the tablet by weight.
    Type: Application
    Filed: July 3, 2002
    Publication date: January 8, 2004
    Inventor: Bernard Charles Sherman
  • Metformin hydrochloride tablets
    Patent number: 6667054
    Abstract: Tablets for oral administration comprising metformin hydrochloride and methylcellulose.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: December 23, 2003
    Inventor: Bernard Charles Sherman
  • Magnesium salt of S-omeprazole
    Publication number: 20030232861
    Abstract: A process of producing the magnesium salt of an enantiomer of omeprazole, said process comprising the steps of:
    Type: Application
    Filed: May 16, 2003
    Publication date: December 18, 2003
    Inventor: Bernard Charles Sherman
  • Tablets comprising ciprofloxacin hydrochloride
    Publication number: 20030229101
    Abstract: A pharmaceutical tablet comprising over 80% by weight ciprofloxacin hydrochloride monohydrate.
    Type: Application
    Filed: June 6, 2002
    Publication date: December 11, 2003
    Inventor: Bernard Charles Sherman
  • Pharmaceutical tablet comprising an NSAID and misoprostol
    Patent number: 6656503
    Abstract: A pharmaceutical tablet comprising a core and a film coating wherein the core comprises an NSAID and the film coating comprises a polymer and misoprostol.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: December 2, 2003
    Inventor: Bernard Charles Sherman
  • Extended release tablets comprising felodipine
    Publication number: 20030211149
    Abstract: An extended-release tablet comprising felodipine, a non-ionic surfactant, and a release-controlling excipient, wherein the amount of surfactant is more than 0.01 part but less than 1.0 part per part felodipine by weight.
    Type: Application
    Filed: May 7, 2002
    Publication date: November 13, 2003
    Inventor: Bernard Charles Sherman
  • Stable saccharide-free tablets comprising a salt of quinapril or moexipril
    Publication number: 20030157165
    Abstract: Saccharide-free tablets comprising a salt of quinapril or moexipril and an alkaline compound and further comprising an excipient that stabilizes against hydrolysis and is either water-soluble or absorbs water.
    Type: Application
    Filed: February 1, 2002
    Publication date: August 21, 2003
    Inventor: Bernard Charles Sherman
  • Metformin Hydrochloride tablets
    Publication number: 20030104049
    Abstract: Tablets for oral administration comprising metformin hydrochloride and methylcellulose.
    Type: Application
    Filed: December 5, 2001
    Publication date: June 5, 2003
    Inventor: Bernard Charles Sherman
  • Solid pharmaceutical compositions for oral administration comprising itraconazole
    Publication number: 20030096014
    Abstract: Co-precipitates of itraconazole and a water-soluble non-polymeric compound. Compositions for oral administration comprising amorphous itraconazole or a co-precipitate, and a disintegrant.
    Type: Application
    Filed: November 5, 2002
    Publication date: May 22, 2003
    Inventor: Bernard Charles Sherman
  • Clopidogrel bisulfate tablet formulation
    Publication number: 20030096837
    Abstract: Pharmaceutical tablets comprising clopidogrel bisulfate and a lubricant selected from zinc stearate, stearic acid, and sodium stearyl fumarate.
    Type: Application
    Filed: November 4, 2002
    Publication date: May 22, 2003
    Inventor: Bernard Charles Sherman
  • Pharmaceutical compositions comprising co-micronized fenofibrate
    Patent number: 6555135
    Abstract: A pharmaceutical composition for oral administration comprising a co-micronized mixture of fenofibrate and a solid excipient that is not a surfactant.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: April 29, 2003
    Inventor: Bernard Charles Sherman
  • Liquid for oral administration comprising paroxetine
    Publication number: 20030078285
    Abstract: An oral liquid pharmaceutical composition comprising paroxetine or a salt thereof and a basic compound which imparts a pH of above 7 to the composition.
    Type: Application
    Filed: October 4, 2002
    Publication date: April 24, 2003
    Inventor: Bernard Charles Sherman
  • Pharmaceutical compositions comprising quinapril magnesium
    Patent number: 6531486
    Abstract: Solid pharmaceutical compositions comprising quinapril magnesium can be made by reacting a quinapril or an acid addition salt thereof with an alkaline magnesium compound in the presence of a solvent so as to convert the quinapril or quinapril acid addition salt to quinapril magnesium.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: March 11, 2003
    Assignee: Apotex Inc.
    Inventor: Bernard Charles Sherman
  • Pharmaceutical composition comprising fenofibrate
    Publication number: 20030031705
    Abstract: The bioavailability of fenofibrate is improved by making a solid dispersion of a disentegrant in the fenofibrate. Method of making said solid dispersion comprising melting the fenofibrate, blending the disintegrant into the melt, and resolidifying the mixture.
    Type: Application
    Filed: July 5, 2002
    Publication date: February 13, 2003
    Inventor: Bernard Charles Sherman
  • Pharmaceutical compositions comprising quinapril magnesium
    Publication number: 20030027837
    Abstract: Stable solid compositions comprising quinapril magnesium can be made using quinapril or an acid addition salt thereof, by reacting the quinapril or acid addition salt with an alkaline magnesium compound in the prsence of a solvent, so as to convert all or substantially all of the quinapril or acid addition salt to quinapril magnesium.
    Type: Application
    Filed: September 25, 2002
    Publication date: February 6, 2003
    Inventor: Bernard Charles Sherman